ASPI
NASD ASP Isotopes, Inc.$2.72 ↑ +0.07 (+2.64%) Trading Up from the previous close of $2.65
- YTD change
- -49.16%
- vs 20-day SMA
- -17.43%
- vs 200-day SMA
- -48.45%
Price ranges
Price & Performance
-1.46 (-35.52%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 81.2% away from all-time highs of $14.49
- ASPI is down 49% since the beginning of the year
- ASPI is down 70% over the past 12 months
- ASPI is down 28% over the past 1 month
- 20% of all ASPI investors are betting against ASPI
ASPI reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -70.8%.
- Previous minute
- +$0.00
- Last hour
- +$0.04
- Last 5 days
- -9.63%
- vs 8-day SMA
- -5.92%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
